<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34669638</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2542-5641</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>20</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Chinese medical journal</Title><ISOAbbreviation>Chin Med J (Engl)</ISOAbbreviation></Journal><ArticleTitle>Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.</ArticleTitle><Pagination><StartPage>2457</StartPage><EndPage>2464</EndPage><MedlinePgn>2457-2464</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CM9.0000000000001693</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Investigations of the pathogenic mechanisms in motor neurons (MNs) derived from amyotrophic lateral sclerosis (ALS) disease-specific induced pluripotent stem (iPS) cell lines could improve understanding of the issues affecting MNs. Therefore, in this study we explored mutant superoxide dismutase 1 (SOD1) protein expression in MNs derived from the iPS cell lines of ALS patients carrying different SOD1 mutations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We generated induced pluripotent stem cell (iPSC) lines from two familial ALS (FALS) patients with SOD1-V14M and SOD1-C111Y mutations, and then differentiated them into MNs. We investigated levels of the SOD1 protein in iPSCs and MNs, the intracellular Ca2+ levels in MNs, and the lactate dehydrogenase (LDH) activity in the process of differentiation into the MNs derived from the controls and ALS patients' iPSCs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The iPSCs from the two FALS patients were capable of differentiation into MNs carrying different SOD1 mutations and differentially expressed MN markers. We detected high SOD1 protein expression and high intracellular calcium levels in both the MN and iPSCs that were derived from the two SOD1 mutant patients. However, at no time did we observe stronger LDH activity in the patient lines compared with the control lines.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MNs derived from patient-specific iPSC lines can recapitulate key aspects of ALS pathogenesis, providing a cell-based disease model to further elucidate disease pathogenesis and explore gene repair coupled with cell-replacement therapy. Incremental mutant expressions of SOD1 in MNs may have disrupted MN function, either causing or contributing to the intracellular calcium disturbances, which could lead to the occurrence and development of the disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wen-Chao</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan-Fang</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Gang</ForeName><Initials>XG</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin Med J (Engl)</MedlineTA><NlmUniqueID>7513795</NlmUniqueID><ISSNLinking>0366-6999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>20</Day><Hour>17</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34669638</ArticleId><ArticleId IdType="pmc">PMC8654443</ArticleId><ArticleId IdType="doi">10.1097/CM9.0000000000001693</ArticleId><ArticleId IdType="pii">00029330-202110200-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014; 17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng M, Wei L, Zuo X, Tian Y, Xie F, Hu P, et al. . Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat Genet 2013; 45:697&#x2013;700. doi: 10.1038/ng.2627.</Citation><ArticleIdList><ArticleId IdType="pubmed">23624525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Homma K, Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul 2016; 60:95&#x2013;104. doi: 10.1016/j.jbior.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SS, Gomes CM. Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front Cell Neurosci 2015; 9:225.doi: 10.3389/fncel.2015.00225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468822</ArticleId><ArticleId IdType="pubmed">26136661</ArticleId></ArticleIdList></Reference><Reference><Citation>Musaro A. Understanding ALS: new therapeutic approaches. FEBS J 2013; 280:4315&#x2013;4322. doi: 10.1111/Febs.12087.</Citation><ArticleIdList><ArticleId IdType="pubmed">23217177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, et al. . Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A 2012; 109:5803&#x2013;5808. doi: 10.1073/pnas.1202922109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326463</ArticleId><ArticleId IdType="pubmed">22451909</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, Degroot S, et al. . Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol 2013; 126:385&#x2013;399. doi: 10.1007/s00401-013-1149-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Chen J, Liu W, Li X, Chen Q, Liu T, et al. . The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation. Neurogenetics 2015; 16:223&#x2013;231. doi: 10.1007/s10048-015-0448-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">25912081</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SSW, Sandoe J, et al. . Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep 2014; 7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunton-Stasyshyn RKA, Saccon RA, Fratta P, Fisher EM. SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes. Neuroscientist 2015; 21:519&#x2013;529. doi: 1073858414561795.</Citation><ArticleIdList><ArticleId IdType="pubmed">25492944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Destroismaisons L, Peyrard SL, Cadot S, Rouleau GA, Brown RH, Jr, et al. . Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum Mol Genet 2013; 22:3947&#x2013;3959. doi: 10.1093/hmg/ddt249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Velde CV, Israelson A, Xie J, Bailey AO, Dong MQ, et al. . ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A 2010; 107:21146&#x2013;21151. doi: 10.1073/pnas.1014862107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000256</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId></ArticleIdList></Reference><Reference><Citation>Guatteo E, Carunchio I, Pieri M, Albo F, Canu N, Mercuri NB, et al. . Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels&#x2019; activation in a genetic model of amyotrophic lateral sclerosis. Neurobiol Dis 2007; 28:90&#x2013;100. doi: 10.1016/j.nbd.2007.07.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">17706428</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El-Escorial world federation of neurology criteria for the diagnosis of amyotrophic-lateral-sclerosis. J Neurol Sci 1994; 124:96&#x2013;107. doi: 10.1016/0022-510x(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Chen J, Li K, Wu T, Huang B, Liu W, et al. . Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 2013; 12:453&#x2013;469. doi: 10.1016/j.stem.2013.02.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">23499384</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2:3081&#x2013;3089. doi:10.1038/nprot.2007.418.</Citation><ArticleIdList><ArticleId IdType="pubmed">18079707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A, Kim K, et al. . A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 2013; 12:238&#x2013;251. doi: 10.1016/j.stem.2012.11.011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570604</ArticleId><ArticleId IdType="pubmed">23246482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YM, Gupta SK, Kim KJ, Powers BE, Cerqueira A, Wainger BJ, et al. . A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 2013; 12:713&#x2013;726. doi: 10.1016/j.stem.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3707511</ArticleId><ArticleId IdType="pubmed">23602540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang L, Wang J, Zhang Y, Kou Z, Gao S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009; 5:135&#x2013;138. doi: 10.1016/j.stem.2009.07.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631602</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao J, Yang Y, Shi Y, Chen J, Gao R, Fan Y, et al. . Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons. Hum Mol Genet 2013; 22:4241&#x2013;4252. doi: 10.1093/Hmg/Ddt275.</Citation><ArticleIdList><ArticleId IdType="pubmed">23773995</ArticleId></ArticleIdList></Reference><Reference><Citation>Le R, Kou Z, Jiang Y, Li M, Huang B, Liu W, et al. . Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells. Cell Stem Cell 2014; 14:27&#x2013;39. doi: 10.1016/j.stem.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">24268696</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Durazo A, Whitelegge JP, Borchelt DR. Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J Neurochem 2009; 108:1009&#x2013;1018. doi: 10.1111/j.1471-4159.2008.05839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801375</ArticleId><ArticleId IdType="pubmed">19077113</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, et al. . Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 2013; 12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A 2009; 106:7774&#x2013;7779. doi: 10.1073/pnas.0902505106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2675570</ArticleId><ArticleId IdType="pubmed">19416874</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, et al. . Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 2003; 12:2753&#x2013;2764. doi: 10.1093/Hmg/Ddg312.</Citation><ArticleIdList><ArticleId IdType="pubmed">12966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Hart PJ, Borchelt DR, Andersen PM. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet 2009; 18:3217&#x2013;3226. doi: 10.1093/Hmg/Ddp260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, et al. . Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 2014; 14:796&#x2013;809. doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn K, Grosskreutz J, Haastert K, Ziegler E, Schlesinger F, Grothe C, et al. . Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons. Neuroscience 2006; 142:1019&#x2013;1029. doi: 10.1016/j.neuroscience.2006.07.034.</Citation><ArticleIdList><ArticleId IdType="pubmed">16949760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, et al. . Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 2014; 14:781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, et al. . Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 2004; 43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, et al. . Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010; 67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrini S, Sau D, Guareschi S, Bogush M, Brown RH, Jr, Naniche N, et al. . ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet 2010; 19:2974&#x2013;2986. doi: 10.1093/hmg/ddq202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2901139</ArticleId><ArticleId IdType="pubmed">20460269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>